Kevin Flanigan, MD, on the Impact of Neuromuscular Disease Gene Therapy Approvals
April 9th 2023The director of the center for gene therapy at Nationwide Children's Hospital discussed the prospect of gene therapy approvals in Duchenne muscular dystrophy and the associated challenges that remain to be addressed.